Bertrand Jaber, MD, MSc, FASN, FNKF

Adjunct Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

Dr. Jaber is the Chair of Medicine and a board-certified internist and nephrologist. He serves as Chair of the Clinical Competency Committee, and Core Faculty for the Internal Medicine Residency Program. Dr. Jaber received his medical degree from St. Joseph University Faculty of Medicine, Beirut, Lebanon, and completed a residency in Internal Medicine at Carney Hospital, Boston, MA, followed by a clinical and research fellowship in nephrology at Tufts New England Medical Center, Boston, MA. He also holds a Master of Science in Clinical Research from the Graduate School of Biomedical Sciences at Tufts University.

Dr. Jaber has had a longstanding commitment to medical education. Over the years, he has been the recipient of numerous teaching awards and citations from medical students and residents, including the St. Luke’s Award in recognition of his dedication and excellence to the education of residents. Dr. Jaber is a member of the Intern Selection Committee and participates extensively in lecture instructions and in hospital- and clinic-based teaching of residents. He also directs the Quality Improvement Curriculum of the residency program.

Dr. Jaber’s research interests and original accomplishments have covered several important areas within the field of nephrology, including biocompatibility of dialyzers, leukocyte dysfunction in uremia, novel dialysis therapies, and the utility of biomarkers in acute kidney injury. He has also made contributions to the field of evidence-based medicine through the conduct of meta-analyses on the prevention and treatment of kidney diseases. He has mentored and supervised scores of trainees through the conduct of quality improvement initiatives and research projects.

Publications

  • Published 4/27/2025

    Alabdul Razzak I, El Naamani H, Dimitrov D, Morin R, Jaber BL. Bile cast nephropathy: A systematic review of case reports and case series. World J Hepatol. 2025 Apr 27; 17(4):105120. PMID: 40308820.

    Read at: PubMed

  • Published 2/1/2025

    Mughrabi A, Maamari J, Phillips T, Alabbasi A, Brooks A, Nuriev R, Zenkin L, Jaber BL, Nader C. Antibiotic treatment of ceftriaxone-susceptible Serratia marcescens bacteremia: A multicenter, retrospective cohort study. Int J Clin Pharmacol Ther. 2025 Feb; 63(2):54-62. PMID: 39744800.

    Read at: PubMed

  • Published 1/10/2025

    Alhaddad J, Allos H, Dimitrov D, Nader CM, Rennke HG, Jaber BL. Minimal change disease in treatment-naïve hepatitis C virus infection: A case report and literature review. Clin Nephrol Case Stud. 2025; 13:1-7. PMID: 39816676.

    Read at: PubMed

  • Published 7/23/2024

    Alabdul Razzak I, Korchemny N, Smoot D, Jose A, Jones A, Price LL, Jaber BL, Moraco AH. Parameters Predictive of Propofol-Associated Acute Pancreatitis in Critically Ill Patients with COVID-19 Pneumonia: A Retrospective Cohort Study. J Intensive Care Med. 2025 Jan; 40(1):67-73. PMID: 39043370.

    Read at: PubMed

  • Published 6/7/2024

    Philipp M, Tessier A, Donnelly M, Fang L, Feng K, Zhao L, Grosser S, Sun G, Sun W, Mentré F, Bertrand J. Model-based bioequivalence approach for sparse pharmacokinetic bioequivalence studies: Model selection or model averaging? Stat Med. 2024 Aug 15; 43(18):3403-3416. PMID: 38847215.

    Read at: PubMed

View All 189 Publications:   View Full Profile in BUMC

Websites

Education

  • St. Joseph's University, MD
  • Tufts University, MSc
  • Collège Mont La Salle, BS

View all profiles